AirSculpt Technologies, Inc. (AIRS) vs Cryo-Cell International Inc. (CCEL)
- AirSculpt Technologies, Inc. AIRS 1.28 −9.86%
- Cryo-Cell International Inc. CCEL 4.42 +21.10%
AirSculpt Technologies, Inc. and Cryo-Cell International Inc. are both Medical Care Facilities companies. AirSculpt Technologies, Inc. is the larger, with a market value of $102.0M against $29.4M — 3.5× the size. Cryo-Cell International Inc. grew revenue faster over the last twelve months: −1.96% against −8.71%. Cryo-Cell International Inc. has the higher net margin (−6.25% vs −7.79%) and the higher return on invested capital (0.00% vs −6.07%). Across the 18 metrics below, Cryo-Cell International Inc. leads on 14 and AirSculpt Technologies, Inc. on 4.
Valuation
Profitability
| Metric | AIRS | CCEL | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 59.73% | 78.54% | 30.78% |
| Operating margin | (8.35%) | 0.61% | 5.74% |
| Net margin | (7.79%) | (6.25%) | 2.32% |
| Free cash flow margin | 0.50% | 14.94% | 5.46% |
| Return on equity | (11.98%) | 12.46% | 8.76% |
| Return on assets | (5.99%) | (3.10%) | 2.18% |
| Return on invested capital | (6.07%) | 0.00% | 5.01% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack